DIA Pharmaceutical, with bold ideas and implementation,
we continue to pioneer new markets, both inside and outside of Japan.
Since its foundation in 1948, the company has conducted in-house research and development of pharmaceuticals and other products to satisiy people's desire for health and beauty. In 1983, these efforts were rewarded with the successful development of the SOLinGEL water-solvent polymer technology. The transdermal absorption type skin adhesive that was developed using this technology opened a new market in the pharmaceutical industry and gave birth to new cosmetic and sundry products such as "cosmetics patch" and "health care patch". Following the Hyogo Factory, which was inaugurated in 1999, the Nara Factory started operations in 2002, steadily reinforcing production of medical drugs (topical and liquid products).
Corporate Profile
| Name | DIA Pharmaceutical Co., Ltd. | |
|---|---|---|
| Address |
Headquarters
|
|
| Established |
March 8th 1948 |
|
| Capital |
66,000,000 JPY |
|
| Representative |
Daizou Morikane, Representative Director |
|
| Trade banks |
Japan Finance Corporation, Nara Branch
|
|
| Major Shareholders |
Kanahashi Holdings Co., Ltd. |
|
| Description of Business |
Production and sale of medical drugs, quasi-drugs, cosmetics, medical devices and tools
|
|
| Affiliate Company |
Shirogane Pharmaceutical Co., Ltd.
|
|